Home
It's where Bluffton gets its news!
HS Sports
November 22, 2019

You are here

Health Services

Manage your diabetes with the ABCs

Note: this article is provided by ONU Healthwise Pharmacy.
If you have been diagnosed with diabetes, you may feel overwhelmed — and that’s understandable. But you can take steps to both ease your anxiety and get on the road to effective diabetes management.

Understand Your Condition

Type 2 diabetes is a condition in which there is too much glucose (sugar) in your blood because your body does not make or use insulin well.

Section: 

FDA approves new injection to treat hives

Note: this article is provided by ONU Healthwise Pharmacy.
There's a newly approved treatment for hives.

The US Food and Drug Administration (FDA) has approved Quzyttir (cetirizine) to treat acute urticaria (hives).

Available as an injection to be given into the vein (IV), this new medication is approved for adults and children 6 months of age and older.

Cetirizine injection is now an alternative treatment option to IV diphenhydramine (brand name Benadryl).

The approved dose is once every 24 hours as needed for acute hives.

Section: 

New migraine med approved

FDA approves Reyvow (lasmiditan)

Note: this article is provided by ONU Healthwise Pharmacy.
A new migraine medication is hitting the market.

The US Food and Drug Administration (FDA) has approved Reyvow (lasmiditan) to treat migraines.

Migraines are estimated to affect more than 10 percent of people around the world.

Lasmiditan, available in tablet form, has been approved for adults with migraines with or without aura.

Section: 

Four mammogram myths debunked

Note: this article is provided by ONU Healthwise Pharmacy.
For Breast Cancer Awareness Month, we're debunking four common mammogram myths.

Section: 

E-Cigs remain under investigation

FDA continues to warn consumers of potential risks of vaping

Note: this article is provided by ONU Healthwise Pharmacy.
Health officials continue to investigate e-cigarettes as the number of reported respiratory problems tied to vaping continues to rise.

Recently, the US Food and Drug Administration (FDA) issued a warning about a possible risk of respiratory issues tied to e-cig products. At the end of August, the FDA stated that 25 states had reported 215 possible cases of such issues.

Section: 

New diabetes medication gets green light

FDA approves Rybelsus (semaglutide) to treat type 2 diabetes

Note: this article is provided by ONU Healthwise Pharmacy.
The US Food and Drug Administration (FDA) has approved a new diabetes medication.

This new approval is found under the names Rybelsus (brand name) and semaglutide (active ingredient). The FDA approved semaglutide to treat adults with type 2 diabetes in combination with diet and exercise.

Section: 

Pages